Shire Partners with Nimbus Discovery to Develop Oral Therapies for Lysosomal Storage Disorders
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 5 (Table of Contents)
Published: 20 May-2013
DOI: 10.3833/pdr.v2013.i5.1941 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In the first deal to emerge from its tie-up with Atlas Venture, Shire has partnered with Nimbus Discovery to develop disease-altering small molecule therapies for lysosomal storage disorders (LSDs)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018